SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-034864
Filing Date
2020-06-05
Accepted
2020-06-05 19:42:51
Documents
2
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12171
2 POA DOCUMENT poa.txt EX-24.4_920488 3157
  Complete submission text file 0001209191-20-034864.txt   16799
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 777 MARINERS ISLAND BOULEVARD SUITE 550 SAN MATEO CA 94404
Business Address
Ericson William W. (Reporting) CIK: 0001503381 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 20947823